Alpha-GPC vs Armodafinil

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

✅ Stacking Partners — These compounds are commonly used together and may have synergistic effects.
Alpha-GPCArmodafinil
CategoryNootropicsNootropics
Standard Dose300-600 mg/day75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)
TimingMorning or pre-workout. Can be taken with or without food. Split into 1-2 doses.Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.
Cycle DurationOngoing; no cycling required for standard dosesSame as modafinil; not typically cycled in clinical use.
Evidence Levelstrong_humanstrong_human
A

Alpha-GPC

Nootropics

Mechanism

Highly bioavailable choline source that crosses the blood-brain barrier efficiently via passive diffusion. Serves as a direct precursor for acetylcholine synthesis and phosphatidylcholine, a major structural component of neuronal membranes. Also stimulates growth hormone release via cholinergic activation of GHRH-releasing neurons in the hypothalamus. Contains ~40% choline by weight.

Standard Dosing

300-600 mg/day

Timing

Morning or pre-workout. Can be taken with or without food. Split into 1-2 doses.

Cycle Duration

Ongoing; no cycling required for standard doses

Side Effects

  • GI distress
  • Headache
  • Dizziness
  • Fishy body odor at high doses
  • Potential TMAO elevation with chronic high-dose use

Contraindications

  • Active peptic ulcer disease
  • TMAO concerns — emerging research links high choline intake to elevated TMAO and cardiovascular risk

Best Stacking Partners

PiracetamAniracetamPramiracetamUridineDHA
B

Armodafinil

Nootropics

Mechanism

The isolated R-enantiomer of racemic modafinil, sharing the same primary mechanism — selective inhibition of the dopamine transporter (DAT) — but with distinct pharmacokinetics. The R-enantiomer has a terminal half-life of ~15 hours vs. ~4-5 hours for the S-enantiomer, resulting in 33-40% higher plasma AUC compared to equimolar racemic modafinil. This translates to more sustained wakefulness-promoting activity throughout the day. Same downstream activation of orexinergic, histaminergic, and noradrenergic pathways as modafinil.

Standard Dosing

75-150 mg once daily (for educational context only — prescription medication in most jurisdictions)

Timing

Early morning. 150 mg armodafinil provides comparable late-day wakefulness to 200 mg modafinil. Food delays Tmax by ~2-4 hours but does not affect total absorption. Half-life approximately 15-16.5 hours.

Cycle Duration

Same as modafinil; not typically cycled in clinical use.

Side Effects

  • Headache
  • Nausea
  • Dizziness
  • Insomnia (more pronounced than modafinil due to longer half-life)
  • Anxiety
  • Dry mouth
  • Diarrhea
  • Stevens-Johnson syndrome (very rare)

Contraindications

  • Same as modafinil: mitral valve prolapse, left ventricular hypertrophy, severe hepatic impairment, severe anxiety/psychotic disorders, hypersensitivity, pregnancy

Best Stacking Partners

L-TheanineAlpha-GPCMagnesium

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →